Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency

被引:62
|
作者
Xu, Y
Clark, JC
Aronow, BJ
Dey, CR
Liu, C
Wooldridge, JL
Whitsett, JA
机构
[1] Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA
[2] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA
[3] Cincinnati Childrens Hosp, Med Ctr, Div Pediat Informat, Cincinnati, OH 45229 USA
[4] Cincinnati Childrens Hosp, Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA
关键词
D O I
10.1074/jbc.M210277200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cystic fibrosis, the most commonly inherited lethal pulmonary disorder in Caucasians, is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). To identify genomic responses to the presence or absence of CFTR in pulmonary tissues in vivo, microarray analyses of lung mRNAs were performed on whole lung tissue from mice lacking (CFTR(-)) or expressing mouse CFTR (CFTR(+)). Whereas the histology of lungs from CFTR(-) an CFTR(+) mice was indistinguishable, statistically significant increases in the relative abundance of 29 and decreases in 25 RNAs were identified by RNA microarray analysis. Of RNAs whose expression was consistently altered by the absence of CFTR, functional classes of genes influencing gene transcription, inflammation, intracellular trafficking, signal transduction, and ion transport were identified. IRNAs encoding the transcription factor CCAAT enhancei-binding protein (CEBP) 5 and interleukin (IL) 1beta, both known to regulate CFTR expression, were induced, perhaps indicating adaptation to the lack of CFTR. RNAs mediating lung inflammation including calgranulin-S100 family members, IL-1beta and IL-4, were increased. Likewise, expression of several membrane transport proteins that interact directly with CFTR were increased, suggesting that CFTR-protein complexes initiate genomic responses. Absence of CFTR influenced the expression of genes modulating diverse pulmonary cell functions that may ameliorate or contribute to the pathogenesis of CF.
引用
收藏
页码:7674 / 7682
页数:9
相关论文
共 50 条
  • [41] The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke
    Raju, S. Vamsee
    Lin, Vivian Y.
    Liu, Limbo
    McNicholas, Carmel M.
    Karki, Suman
    Sloane, Peter A.
    Tang, Liping
    Jackson, Patricia L.
    Wang, Wei
    Wilson, Landon
    Macon, Kevin J.
    Mazur, Marina
    Kappes, John C.
    DeLucas, Lawrence J.
    Barnes, Stephen
    Kirk, Kevin
    Tearney, Guillermo J.
    Rowe, Steven M.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 56 (01) : 99 - 108
  • [42] Cystic fibrosis transmembrane conductance regulator biomarkers in "real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
    van Koningsbruggen-Rietschel, Silke
    Naehrlich, Lutz
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (04) : 198 - 200
  • [43] Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator
    Frauke Mekus
    Manfred Ballmann
    Inez Bronsveld
    Thilo Dörk
    Jan Bijman
    Burkhard Tümmler
    H. J. Veeze
    Human Genetics, 1998, 102 : 582 - 586
  • [44] CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR AND THE ETIOLOGY AND PATHOGENESIS OF CYSTIC-FIBROSIS
    MCINTOSH, I
    CUTTING, GR
    FASEB JOURNAL, 1992, 6 (10): : 2775 - 2782
  • [45] The ROMK-cystic fibrosis transmembrane conductance regulator connection: new insights into the relationship between ROMK and cystic fibrosis transmembrane conductance regulator channels
    Ho, K
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1998, 7 (01): : 49 - 58
  • [46] Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators
    Vargas-Roldan, Silvia Y.
    Lezana-Fernandez, Jose L.
    Cerna-Cortes, Jorge F.
    Partida-Sanchez, Santiago
    Santos-Preciado, Jose, I
    Rosales-Reyes, Roberto
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2022, 79 (04): : 215 - 221
  • [47] Cystic Fibrosis Transmembrane Conductance Regulator Mutation Spectrum in Patients with Cystic Fibrosis in Tunisia
    Fredj, Sondess Hadj
    Messaoud, Taieb
    Templin, Carine
    des Georges, Marie
    Fattoum, Slaheddine
    Claustres, Mireille
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2009, 13 (05) : 577 - 581
  • [48] Cystic fibrosis: candidate selection and impact of the cystic fibrosis transmembrane conductance regulator therapy
    Lehr, Carli J.
    Pilewski, Joseph M.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2022, 27 (03) : 198 - 203
  • [49] Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis
    Sloane, Peter A.
    Rowe, Steven M.
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (06) : 591 - 597
  • [50] Treatment of Fetal Cystic Fibrosis With Cystic Fibrosis Transmembrane Conductance Regulator Modulation Therapy
    Blumenfeld, Yair J. J.
    Hintz, Susan R. R.
    Aziz, Natali
    Barth, Richard A. A.
    Spano, Jacquelyn M. M.
    El-Sayed, Yasser Y. Y.
    Milla, Carlos
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (07) : 1015 - 1016